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Thesis Summary 
Peripheral Arterial Disease is a growing epidemic throughout the United 
States. It is estimated that 8 to 12 million Americans currently suffer from PAD, a 
disease of the circulatory system that limits blood flow to your hands and feet. 
This limited blood flow is due to the narrowing of the arteries that supply blood 
throughout your body and can disrupt the balance of the nerves and tissues that 
make up your extremities. If left untreated, it can cause irreparable, life-
threatening damage that may result in amputation of the diseased limb. Although 
the mechanism of PAD is known and well understood, different treatment options 
are still being researched and evaluated in order to fully understand which is the 
most effective and efficient for each clinical presentation. 
The least invasive treatment options are lifestyle changes, including the 
implementation of exercise regimes or medical therapy in an effort to control the 
primary causes of PAD. However, these may be met with limited success, and 
greater more invasive intervention may be necessary. Surgical treatment options 
usually include the use of a long wire to reach the obstructed region of the blood 
vessel and remove the plaque. In rare cases, it may be necessary to use a man-
made artery in order to create an alternate route for blood to flow around the 
occluded segment. All of these surgical interventions require the use of an 
imaging technique in order to both navigate through the arteries to the obstructed 
segment and view the plaque accumulation inside the vessel.  
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Angiography has long been considered to be the best method for 
navigating through the different arteries of the leg, even though its ability to view 
the accumulated plaque is adequate at best. In recent years, intravascular 
ultrasound has shown to be capable of providing more accurate details regarding 
the vessel lumen, plaque shape, and composition as compared to angiography. 
A greater understanding of these components aids in both the diagnostic and 
treatment process. Intervening physicians are able to gain a greater 
understanding of where the obstruction is located and how bad it is, which allows 
them to better decide if intervention is necessary. In addition, in the event that 
intervention is warranted, greater knowledge regarding the plaque shape and 
composition allows them to choose the interventional technique that will produce 
the best outcome for the patient.  
The solution to the current lack of information most likely comes in the 
form of using IVUS in adjunct with angiography during interventional procedures. 
This would allow the intervening physician to both navigate to the right location 
and view the extent of the plaque accumulation. IVUS, however, is currently 
limited by its cost of implementation, which can range anywhere from $70,000-
$120,000 for a basic system, in addition to a $600 disposable catheter tip per 
patient. As research continues to develop, new solutions and technological 
advancements may help lower the costs of the existing technology.  
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Introduction 
Peripheral arterial disease (PAD) is a disease of the circulatory system 
classified by the narrowing and hardening of the arterial wall due to the buildup of 
fatty deposits called plaque. PAD affects at least 8 to 12 million Americans, and 
one in every three people 70-years of age or older has PAD.1 As plaque fills the 
arterial wall, blood flow distal to the obstructed region is reduced. If the blood 
volume provided to the distal vasculature is not sufficient to keep up with the 
tissue’s oxygen demands, damage to the nerves or tissue may occur. There are 
many risk factors – conditions that increase the risk of disease or infection – 
associated with PAD, including: smoking, old age, diabetes, hyperlipidemia, 
hypertension, and renal insufficiencies. These risk factors may also lead to other 
co-morbidities such as Coronary Artery Disease and heart attacks or strokes. If 
left untreated, PAD can progress into a Critical Limb Ischemia, a more serious 
form of PAD that can result in chronic pain and/or numbness in the feet or toes, 
nonhealing wounds or ulcers, tissue necrosis (gangrene), and even amputation 
of the affected limb. PAD is also likely to be a sign of widespread accumulation of 
fatty deposits within the arteries of other areas of your body.  
When diagnosing patients suspected of PAD, physicians utilize a sliding 
scale of diagnostic tests ranging from least invasive to most invasive. Although 
each patient’s presentation will ultimately determine his or her treatment, the 
general procedure is as follows. After collecting their medical and family history, 
the physician usually conducts a physical exam that checks blood flow for weak 
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or absent pulses and compares blood pressure between the left and right side of 
the circulatory system (measured at the brachial artery of each arm). Then, 
further non-invasive testing is conducted in order to determine the general 
progression of atherosclerosis. The Ankle-Brachial Index compares blood 
pressure in your ankle to blood pressure in your arms, with a normal reading 
ranging from 0.9 to 0.13. The Segmental Leg Pressures test leg pressures at the 
ankle, blow the knee, above the knee, mid-thigh, wrist, below the elbow, above 
the elbow, and mid upper arm. By identifying the location with the greatest drop 
in blood pressure, it is possible to narrow down the location of the possible 
arterial occlusion to a certain segment. 
Treatment 
Treatment begins with lifestyle changes that minimize the risk factors for 
PAD, such as the implementation of exercise regimes or smoking cessation. In 
addition, medical therapy and pharmaceutical options may be undertaken in an 
effort to lower cholesterol, prevent blood clots, or minimize pain. Surgical 
treatments are only considered if the previously mentioned treatment options fail.  
Angioplasty and stenting procedures utilize a system of guide wires and 
catheters with a balloon at the tip. The tip is inserted into the artery and inflated, 
pushing the plaque outward into the arterial wall. A small mesh tube is then 
placed in the artery to help maintain the patency of the vessel. Atherectomy is a 
similar procedure in which the balloon tip of the catheter is replaced by a small 
cutting device that is inserted into the artery and used to remove the plaque 
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burden. Finally, the most invasive option, a bypass graft, uses a blood vessel 
from another part of the body or a man-made tube to bypass the occluded arterial 
segment. Amputation of the diseased leg is reserved as a last resort in the event 
that the patient’s life is in danger. Treatment decisions are ultimately dependent 
upon the characteristics of the stenosis as well as the symptoms and co-
morbidities of the patient.  
Imaging Modalities 
Vascular surgeons, cardiologists, and radiologists alike rely heavily on 
imaging modalities for both diagnostic and procedural assistance when treating 
patients with PAD. Angiography has long been considered the “gold standard” for 
investigating the vessel lumen, defining peripheral vasculature, and providing 
arterial navigation during percutaneous procedures.2 Typically, cardiologists use 
a system of guide wires and catheters to inject a contrasting agent into the 
femoral artery. They can then use X-ray imaging to view the dye, which shows up 
by absorbing the X-rays, as it passes through the blood vessel of interest. 
 Angiography is capable of depicting characteristics of both the lumen and lumen-
border interface, allowing for evaluation of atherosclerotic plaque burden and 
morphology.3 Image accuracy is limited by arterial wall motion artifact, vessel 
tortuosity, overlying structures, or overlapping vessels, which may reduce 
accurate interpretation regarding the extent of the plaque burden, although this 
can be overcome to some degree with multiplanar imaging. 3,4 To produce 
multiplanar images, the arm of the X-ray machine is rotated to provide different 
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visual planes of the arterial lumen. Angiography depicts the contour of the lumen, 
but cannot quantitatively evaluate the level of atherosclerotic plaque buildup, 
often resulting in misleading interpretations of stenosis.5,6 In addition, luminal 
stenosis from angiography may not be in agreement with more accurate 
quantitative measurements by intravascular ultrasound or histological analysis.6 
These discrepant results may make the need for endovascular intervention 
difficult to determine.  
When treating patients suffering from PAD, the inability to objectively 
evaluate plaque burden, composition, morphology, and vessel wall architecture 
through angiography has led to underestimated arterial dimensions and degrees 
of stenoses, which further limits thorough evaluation of the various interventional 
options, let alone whether or not intervention is necessary.3,7 As a result, 
angiography may contribute to reduced long-term procedural success rates 
during endovascular interventions as compared to IVUS, resulting in increased 
rates of restenosis, thrombosis, and other post-procedural complications. 
Although the intervening physicians are dependent on angiography for arterial 
navigation, intravascular ultrasound (IVUS) has shown potential to assist in both 
diagnostic and interventional procedures by providing intraluminal cross-sectional 
images with higher image resolution than angiography.  
Similar to angiography, IVUS utilizes a system of guide wires and 
catheters in order to collect information; however, IVUS deploys a miniature 
ultrasound device on the distal end of the catheter that allows the operator to see 
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through the surrounding blood column and visualize the inner wall of blood 
vessels from inside the vessel itself. Percutaneous IVUS catheters capture cross-
sectional images that enable 360°-intraluminal visualization of peripheral 
vasculature. A revolving transducer on the catheter tip emits ultrasound waves 
during pullback of the probe through the vessel segment of interest. The axial 
scan uses a grey scale to differentiate amplitudes of reflecting ultrasound waves 
from different tissue types, enabling the categorization of different plaque types 
according to their composition. Calcified plaque reflects brightly because it 
impedes ultrasound waves, appearing white, while thrombus is much more 
hypoechoic and reflects dark grey.8 The close proximity of the probe allows for a 
higher frequency ultrasound to be used, which in turn provides higher image 
resolution and magnification compared to other imaging techniques. This enables 
more accurate assessment of vessel or lesion diameters and lengths, plaque 
shape, length, volume, composition, and concentricity, as well as the 
completeness of treatment after intervention.9 IVUS is also capable of stacking 
consecutive images in order to create a 3-D image of the plaque. These detailed 
images and cross-sectional measurements, when used in adjunct with 
angiography, can increase the capability and accuracy of diagnostic and 
interventional procedures for patients with PAD. Each image has the potential to 
uncover critical information that can be utilized to increase technical success and 
long-term outcomes. 
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Stenosis 
Angiography details the continuity of the peripheral vasculature through 
representation of the vessel lumen.5 Evidence of stenoses can be measured 
through decreases in the luminal area; theoretically, as plaque begins to 
accumulate along the vessel wall the cross-sectional area should decrease and 
limit distal blood flow. However, histological analysis has shown that the elasticity 
of the external elastic membrane (EEM) allows the arterial walls to expand 
centrifugally in order to accommodate the accumulating plaque.6 Because of this 
positive remodeling of the EEM, the lumen area may remain unchanged until 
40% of the cross-sectional area is filled with atheroma deposits.6 Only after full 
expansion of the arterial wall does further atheroma deposits begin to encroach 
into the lumen. Even with multiple projections, angiographic evidence of stenoses 
to support intervention is usually undetectable until the plaque covers 40-50% of 
the total cross-sectional area of the artery.7 
Kashyap et al. researched the effects of positive remodeling in minimally 
diseased arteries with apparent stenosis <30%. Both linear and area stenosis 
levels of popliteal artery segments were evaluated using angiography and 
histological analysis of the internal elastic lamina (IEL). They determined that 
their angiographic scoring of atherosclerotic burden (18.5%) consistently 
underestimated the level of atherosclerosis when compared with the histological 
findings (34.9%). Because angiography uses luminal diameter measurements to 
calculate geometric dimensions, both IEL and vessel area stenosis 
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measurements produced increasingly discrepant results compared to 
angiography, 39.2 (p<0.0001) and 60.9 (p<0.0001) respectively.3 
While angiography repeatedly underestimates stenoses when compared 
with histological analysis, IVUS is capable of providing accurate luminal 
dimensions to monitor plaque progression, in addition to offering additional 
information on the arterial wall.3,10 IVUS correlates as high as 95% with 
angiography when calculating luminal diameters, but is capable of determining 
true vessel wall dimensions in both diseased and normal arteries. These more 
accurate measurements account for positive remodeling and any plaque burden 
not identified by angiography, increasing the accuracy when computing stenosis 
area.11 Using true arterial dimensions to compute the maximal percent area 
stenosis, IVUS determined a 10% degree of stenosis was unaccounted for by 
angiography, most likely because luminal diameter measurements do not 
account for positive remodeling.4 
In addition to greater accuracy, IVUS is capable of surveying blood flow 
within the lumen when using frequencies greater than 30MHz. This information 
can replace subjective angiographic assessment of stenoses area with 
quantitative measurements, enabling more accurate evaluation of stenoses while 
still compensating for vascular remodeling.4,8 The discrepancy between actual 
and inferred stenoses levels imposes severe limitations when evaluating the 
need for endovascular intervention.  
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Vessel Wall Morphology 
Information on the interaction between plaque and the vessel wall is 
essential when investigating peripheral atherosclerosis. The cross-sectional 
diameter of the lumen is calculated with angiography by using the lumen 
diameter dimensions. However, this method is best suited for concentric lesions, 
as accuracy tends to decrease as the level of ellipticity increases.12 Angiography 
is unable to provide this information accurately because of its limited ability when 
defining dimensions of obstructed or irregular vessel segments. Angiography 
overestimates the true lumen cross-sectional diameter compared with IVUS for 
non-elliptical or irregular lumens because vessel wall architecture cannot be 
accurately determined. This can result in an underestimation of lesion stenosis in 
diagnostic studies or overestimation in the beneficial results of intervention.6  
Analysis of the high-resolution images captured by IVUS may provide 
insight into morphological characteristics of the vessel wall, plaque identification, 
and location of lesions. This additional information can be used to analyze 
mechanisms of plaque progression or recession and vessel-plaque interaction.13 
In addition, the accurate measurements of maximum and minimum lumen 
diameters enable calculation of the ellipticity index for each IVUS image. The 
ellipticity index is the ratio of the maximum luminal diameter to the minimum 
luminal diameter and defines the ellipticity for individual images.12 As the index 
increases, the imaged lumen becomes more elliptic. Compared to angiography, 
IVUS images and their morphological analysis produce more detailed information 
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regarding the location, eccentricity, and cross-sectional area of the lumen.12 
Accurate interrogation of vessel wall morphology may also be beneficial for 
determining plaque characteristics, branch vessel location, and the extent of 
disease involvement.14  
Plaque Shape 
Atherosclerotic plaque can accumulate in many different shapes and 
lengths depending on spatial location and composition, but lesions are generally 
classified as concentric or eccentric along with their fiber composition if it is 
known. The shape in which atherosclerotic plaque accumulates is largely 
determined by the curvature and elasticity of the inner arterial wall because 
atherosclerotic plaque components tend to coagulate in areas of low shear 
stress.2 Angiographic methods misrepresent plaque shape and volume because 
of limitations for determining true arterial dimensions and compensating positive 
or negative remodeling.7 While the operator can determine if stenosis is present, 
detailed anatomical characteristics are unreliable even with multiple projections 
of the diseased segment. On the other hand, the axial images IVUS produces 
allows for evaluation of both lumen and true arterial diameters. By comparing the 
true and luminal diameter measurements, it is possible to recreate the diseased 
segment in order to accurately identify plaque architecture and volume.  
Arthurs et al. documented the disassociation of plaque shape between the 
two imaging modalities when they analyzed 93 patients with peripheral arterial 
disease. Their angiographic data showed a shorter length of stenosis at 14.3mm, 
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which underestimated the IVUS findings of 17.3mm by 3mm (20%).4 When 
examining lesion concentricity, their IVUS results produced over twice as many 
concentric lesions (60%) as compared to their angiographic results (28%), 
showing that the angiographic operators were much more likely to overestimate 
the ellipticity index for target lesions.4 
In further evaluation of the findings from Arthurs et al., Kashyap et al. 
compared concentricity data from angiographic and histological plaque 
evaluations. Angiography underestimated plaque concentricity finding 23 of 59 
(39%) plaque evaluations were concentric compared to 35 of 65 (54%) 
concentric plaque evaluations from the histological analysis.3 Because most 
atherosclerotic lesions are eccentrically located within the vessel, it would be 
necessary to use multiplanar angiographic views to adequately evaluate the 
degree of stenosis for a specific lesion.14 It is plausible to conclude that the 
increased accuracy for computed measurements and the more accurate 
concentricity findings are the result of the more accurate geometric data analysis 
from IVUS over other imaging modalities when determining both true and 
diseased diameters.  
Plaque Morphology 
When evaluating therapeutic options for PAD patients, plaque morphology 
and target lesion information are helpful in predicting success rates of different 
endovascular treatments. The information IVUS provides can help predict how 
the target lesion will respond to therapeutic procedures and predict its interaction 
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with blood flow and the vessel wall; these events will determine if the plaque will 
resist recoil and balloon/stent deployment or be liable to embolization, dissection, 
and/or perforation.15 Histological analysis can be used to analyze plaque 
characteristics and determine composition, but this cannot be done in vivo 
because the necessary tissue samples can only be obtained at autopsy. 
Advancements in IVUS modalities, such as virtual histology IVUS (VH-IVUS) and 
integrated backscatter IVUS (IB-IVUS) have facilitated the collection of the 
necessary structural information in situ as well as the ability to assess plaque 
morphology.13 
Virtual Histology IVUS (VH-IVUS) 
VH-IVUS is capable of providing valuable histological data for plaque by 
analyzing the frequency and amplitude of backscattered radiofrequency (RF) 
data and comparing the acquired information to RF spectral profiles based on the 
echogenicity of different tissue types.2,13 The reflecting signals are combined 
through a process known as synthetic aperture to recreate the image.13 When 
recreating the image, VH-IVUS uses the RF spectral profiles to classifies lesions 
in situ into color-coded categories based on four different histological 
components of plaque: dark green: fibrous; yellow-green: fibro-fatty; white: 
calcified; and red: necrotic lipid core.2,4,16  
Although peripheral applications are still being researched, VH-IVUS in the 
coronary has proved to be fairly accurate when compared with histological 
analysis. Diethrich et al. compared thirty carotid plaque samples with their true 
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histological results and recorded high correlations between the two histologies, 
ranging from 72.4% (calcified fibroatheroma) to 99.4% (thin-cap fibroatheroma). 
The results showed a strong correlation between VH-IVUS and histological 
plaque characterization, especially in vulnerable plaque types, providing support 
to the diagnostic accuracy of VH-IVUS.16 For comparison, IVUS correctly 
identified calcium in 100% of the histopathology samples containing calcium, 
while angiography identified only 54% and gray-scale IVUS missed one lesion.16 
The accuracy levels for defining plaque morphology depicted instill confidence for 
using VH-IVUS to track progression of atherosclerotic plaque volume and 
changes to plaque composition.13  
The ability to accurately analyze the morphology, spatial arrangement, and 
geometric dimensions of vulnerable or calcified plaque types aides in the 
evaluation of endovascular interventions and the selection of the appropriate 
therapy.  Other imaging methods are limited by reproducibility from the operator’s 
ability to adjust intensity, frame average, and power level.13 Spectral analysis of 
the pure RF backscatter data signals to determine lumen and vessel area as well 
as plaque burden and composition has shown to have high correlation 
coefficients (<0.90) and reproducibility rates similar to tradition IVUS 
measurements.17 The reproducibility of VH-IVUS enables the quantitative 
spectral measurements to act as a definitive standard when evaluating plaque 
composition.13 The ability to accurately determine the different histological 
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constituents of targeted plaque lesions in situ will be beneficial to facilitating 
further understanding of different mechanisms related to PAD.  
Plaque Calcification 
Identifying plaque histology in situ is particularly helpful in identifying the 
presence of calcified plaque. Calcified plaque is much harder compared to 
fibrous plaque and can have many implications for patients with PAD, especially 
regarding therapeutic options because of the decreased elasticity of the diseased 
vessel segment. The specific shape, volume, and location of the calcified plaque 
are essential factors when determining which interventional procedure is most 
applicable, as more complex plaque and rapid plaque growth by area has been 
associated with risk of stroke and heart attack. For example, during balloon 
angioplasty, higher levels of plaque calcification will require increased balloon 
inflation pressures compared to soft atherosclerotic plaque. The correct balloon 
pressure is essential in order to prevent adverse effects or vessel disruption from 
over-inflation. Contrarily, the softer, more fibrous lesions have greater elasticity 
and may be treated with additional stenting and/or atherectomy to prevent 
negative remodeling.10  
Kashyap et al. quantified the limits of angiography in determining plaque 
calcification by comparing angiographic evaluations to true histological results. 
Angiographic evidence was used to differentiate plaque calcification into four 
groups: none, minimal, moderate, and severe. Their results showed angiography 
underestimated plaque calcification, with 15% of scores recording no calcification 
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compared to 0% of histology. In addition, angiographic evidence identified 15% of 
the samples as severe calcification, compared to 34% by histology. 
Angiography’s inability to produce quantifiable plaque calcification data leads to 
subjective interpretation, which appears to be the primary cause for the 
discordant results. This conclusion was further supported by the relatively low 
intraobserver reliability reported from the study (0.3985).3 These results not only 
speak to the limits of angiography, but also to the need for a definitive standard 
for quantifying calcified plaque in situ.  
Calcified plaque can be identified through the bright white locations 
depicted on IVUS images, providing interventionalists a better understanding of 
lesion morphology, shape, and location. During atherectomy procedures, the 
location of calcified plaque is directly related to the methodology used during 
treatment. For example, high-speed rotational atherectomy is best suited for 
superficial plaque close to the lumen surface. However, if the calcified plaque is 
deep within the vessel wall in contact with the media, directional atherectomy 
may be more appropriate.5 For these reasons, objective measurements on 
specific plaque morphologies using IVUS are more valuable than the subjective 
angiographic representation when selecting the appropriate therapy and 
predicting results of the different interventions.  
Technical Guidance 
IVUS has a wide variety of clinical applications because of the numerous 
data points that can be computed pre-, during, and post-therapeutic intervention. 
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IVUS can provide assistance through accurate evaluation of the diseased and 
true vessel dimensions, cross-sectional area, arterial wall architecture, lesion 
dimensions, plaque morphology, concentricity, and virtual histology. From 
conventional stenting to balloon angioplasty to atherectomy, IVUS imaging 
results can be easily interpreted to provide essential information that adds real-
time technical guidance to intravascular procedures.  
IVUS’ ability to image entire vessel segments, including the lumen, wall, 
and lesions, facilitates diagnosis and intervention in patients with PAD. True 
arterial dimensions that include angiographically silent stenosis and vascular 
remodeling can be compared to lumen measurements to determine lesion 
morphology and the need for intervention. In diseased segments, IVUS obtains 
reference data for specific vessel locations both proximal and distal to the target 
lesion. These reference points define target areas for the interventional 
procedure and allow for more accurate vessel and lesion analysis.2 Accurate 
reference segments and vessel dimensions are equally beneficial for determining 
correct device sizing so that all secondary plaque distal and proximal to the 
stenosis will be treated. Many recent studies have recorded the positive effects of 
IVUS on long-term clinical outcomes, some of which suggest that fewer post-
operational complications reduce the need for re-intervention, potentially 
offsetting the original invested procedural costs.5,10,14  
Interventional cardiologists often use intravascular stents in adjunct with 
balloon angioplasty to improve patient outcomes by compressing plaque outward 
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against the inner arterial wall in order to maintain patency of the arterial lumen.14 
Non-stented lesions treated with angioplasty alone have shown restenosis from 
negative remodeling and elastic recoil of the treated vessel.11 Both immediate 
and long-term patency of stented lesions appears to be directly related to proper 
stent deployment, as determined by three factors: full stent expansion, complete 
apposition to the vessel wall, and full lesion coverage during stent placement.10 
Angiography provides luminal rather than true vessel measurements – that 
include the plaque accumulation – when determining the appropriate stent size, 
relying on subjective interpretation compared to the objective measurements of 
IVUS.4 In addition to the precise measurements that enable more accurate stent 
sizing, IVUS images showing the lesion and the stent-wall interface facilitate 
more accurate stent positioning and expansion.9 
Before stent deployment, IVUS can accurately assess the correct size to 
which a vessel should be dilated. If the stent is not fully apposed to the vessel 
wall, platelets, fibrin, and thrombus can accumulate between the stent and 
arterial wall, forming a lesion that may serve as the starting point for restenosis.11 
On the other hand, stent oversizing or overexpansion severely increases rates of 
ischemic complications such as perforated or ruptured vessels.11  After device 
implantation, IVUS can evaluate device placement, ensuring full device 
expansion with complete stent-vessel wall apposition and no prolapsed plaque.10 
The confirmation IVUS images provide may reduce complications - such as 
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missing the lesion location, stent malapposition, or dislodged stents during 
implantation – that are associated with in-stent restenosis.11 
Arko et al. documented vessel diameters in 25 of 40 lesions (62%) were 
underestimated when using angiography as compared to IVUS analysis. As a 
result, 16 of 40 (40%) stented lesions were under-deployed by IVUS evaluation, 
but appeared adequately expanded through angiography. They concluded 
arteriography was of limited value for evaluating adequate stent expansion.10 In 
further support, Clifford et al. documented 20 of 49 (41%) stents were determined 
to be under-deployed by IVUS evaluation, even though angiography had depicted 
adequate expansion.14  
In addition to assisting in stenting and balloon angioplasty, true vessel 
analysis has proven to be beneficial for atherectomy procedures. The ability to 
quantify plaque volume in a vessel segment has enabled in-depth evaluation of 
plaque removal techniques. Limitations on data analysis from angiographic 
images allow for interpretation of changes in lumen space. As a result, 
angiography has limited ability when attempting to differentiate between plaque 
removal and vessel wall expansion because both mechanisms increase lumen 
diameter. If vessel wall expansion were present, compensatory stretching would 
increase lumen diameters, resulting in misleading angiographic evidence of 
plaque removal. IVUS images offer definitive results due to the quantitative data 
available from true vessel evaluation.6 IVUS may also offer further technical 
guidance during atherectomy through proper blade orientation with respect to the 
	  	   21	  
target lesion, maximizing plaque removal while reducing inadequate debulking 
and vessel perforation.5  
Complications 
Although angiography and other imaging modalities have facilitated 
successful advancement of endovascular interventions, many procedures are still 
plagued by immediate or long-term complications. During intervention, vessel 
morphology is distorted making it difficult to analyze and quantify procedural 
success from comparing post-operative results to pre-operative evaluations.6 In 
addition, many interventional procedures are complex with multiple mechanisms 
that can cause complications such as excess residual stenosis, restenosis, stent 
malapposition, or stent thrombus. Accurate images are necessary to help reduce 
the possibility of post-procedural complications and assess the completion of 
treatment. IVUS analysis provides the information required to increase 
interventional success rates and ensure thorough treatment.  
Aside from malapposition or stent thrombus, other complications such as 
restenoses or occlusions can result from the loss of arterial patency following 
angioplasty or stenting. Residual stenosis data can quantify initial procedural 
success and depict immediate changes in lumen area. Angiographic 
interpretation following directional atherectomy has shown to underestimate 
residual stenosis, identifying 21% residual plaque volume compared to the 48% 
from IVUS evaluation.5  
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Moderate to long-term procedural success is determined through 
evaluation of the vessel lumen patency. Late obstructions to blood flow can result 
from restenosis, occlusions, or stent failure. Clifford et al. researched the 
influence of IVUS in addition to angiography compared with angiography alone 
on the long-term patency of arterial lesions treated with balloon angioplasty and 
primary stenting. After treating 49 limbs using IVUS and angiography, there were 
no restenoses or occlusions recorded. The five-year patency rate was 100% and 
no limbs needed additional treatment or evaluation because of suspected 
restenoses or occlusions. However, after treating 22 limbs using angiography 
alone, early restenosis or occlusion of stented lesions occurred in 4 limbs (18%). 
The five-year patency rate was 82% and two cases of each severe stenoses and 
occlusions were documented. In all four cases, subsequent IVUS evaluation 
found under-deployed stents and additional intervention was needed. Including 
two late failures from the angiography alone group, secondary procedures were 
performed on 5 out of the 22 limbs evaluated (23%). They concluded IVUS 
significantly improved long-term patency by correctly defining the optimal 
angioplasty diameter endpoint and adequacy of stent deployment during the 
initial procedure.14 
A similar study by Frank et al. documented long-term patency data from 
IVUS and angiographic analysis of 52 patients after balloon angioplasty and 
stenting of atherosclerotic aortoiliac occlusive lesions. While none of the 36 
IVUS-assisted patients had restenoses or occlusions, 4 of the 16 (25%) patients 
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assisted by angiography alone developed restenoses or occlusions. All four were 
found to have under-deployed stents and were subsequently treated with 
adequate stent redeployment using IVUS criteria. These lesions remained patent 
and continued to do so at the time the study was concluded four years later. In 
the IVUS-assisted group, IVUS found 40% of the stents were under-deployed, 
even though they appeared adequately expanded on angiography.10 They 
concluded IVUS is possibly the best imaging method for assessing adequacy of 
arterial stent deployment, which may then improve long-term clinical outcomes of 
balloon angioplasty and stented aortoiliac occlusive lesions.11 
Limitations 
Even with all of the benefits IVUS has to offer during endovascular 
interventions, there are some limitations to the technology, especially its 
implementation. The biggest inhibitor of widespread integration of IVUS systems 
is the associated costs of operation. Each disposable catheter-delivered 
transducer costs approximately $500. The IVUS systems themselves can cost 
between $70,000-$120,000 and require a trained technician to operate. On 
average, the additional cost-per-case is approximately $1,000. However, 
although there is a substantial upfront cost, investing in IVUS pays dividends 
once the increased diagnostic abilities, technical guidance, and success rates are 
factored in. Each failed endovascular procedure can costs around $12,000-
$15,000 to salvage. The increased success rate will allow catheterization labs to 
recover their initial investment in lieu of the operational costs for reinterventions.14 
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During the study performed by Clifford et al., if IVUS had salvaged the four 
failures from the arteriography alone group during the initial treatment, the money 
saved from not performing the four reconstructions would have paid for its use in 
all 52 patients.14 
Other limitations of IVUS are associated with its clinical applications or 
analysis. Using a manual pullback system has the potential to cause inconsistent 
retraction rates of the transducer, which could result in incorrectly stacked 
images or poor image quality.8 IVUS also mandates additional time, equipment, 
and personnel. In addition, there is no standard present between manufacturers, 
so IVUS catheters cannot be interchanged.4 However, in experienced hands, 
using an integrated IVUS system adds only a few minutes to procedural time. 
The information is both information, necessary, and easy to interpret because of 
the analysis software and color-coded maps of VH-IVUS.  
Conclusion 
Angiography is adequate for viewing luminal characteristics, but has 
repeatedly been shown to provide inaccurate measurements without providing 
insight into the vessel or plaque morphology. As geometric measurements 
become more complex, evaluating stenosis areas, concentricity, and treatment 
analysis with angiography has shown to produce increasingly discrepant results 
when compared to IVUS. IVUS imaging and analysis software is capable of filling 
the gaps with objective, quantifiable data that provides accurate analysis and 
evaluation of the diseased and true lumen, lesions, and vessel walls. This is 
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particularly true in significantly diseased vessels, in which IVUS can provide more 
accurate evaluation of vessel wall and lumen morphology as well as plaque 
distribution.12  
In addition, IVUS has many clinical applications during interventional 
procedures and has demonstrated positive effects on technical guidance, 
treatment analysis, and long-term patency rates. With continuing advances in 
therapeutic options, the success of interventional procedures may be directly 
related to the capabilities of the accompanying guidance system. However, it is 
important to note that angiography may still play a role in preliminary diagnosis 
and peripheral navigation of the arterial vasculature. Ideally, IVUS should be 
used in conjunction with angiography in order to incorporate the beneficial 
aspects of both imaging modalities. 
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